0001683168-24-002285.txt : 20240410 0001683168-24-002285.hdr.sgml : 20240410 20240410215115 ACCESSION NUMBER: 0001683168-24-002285 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240408 FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cockroft Bettina M. CENTRAL INDEX KEY: 0001900452 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39126 FILM NUMBER: 24837005 MAIL ADDRESS: STREET 1: C/O ANNEXON, INC. STREET 2: 180 KIMBALL WAY, SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001729427 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822318545 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 1-800-946-9185 MAIL ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 4 1 ownership.xml X0508 4 2024-04-08 0 0001729427 CNS Pharmaceuticals, Inc. CNSP 0001900452 Cockroft Bettina M. C/O CNS PHARMACEUTICALS, INC 100 WEST LOOP SOUTH, SUITE 900 HOUSTON TX 77027 1 0 0 0 0 Option to purchase common stock 0.2586 2024-04-08 4 A 0 17500 A 2034-04-08 Common Stock 17500 35574 D Restricted Stock Units 2024-04-08 4 A 0 17500 A Common Stock 17500 53074 D The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date. The awards were issued in connection with the reporting person's Board of Director services to the Company. Each restricted stock unit represents a contingent right to receive one share of the Company common stock. /s/ Christopher Downs, Attorney-in-fact 2024-04-10